Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells ...
The FDA has granted priority review to the new drug application (NDA) for gedatolisib, a first-in-class multi-target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results